An interventional study of Hand therapy (18 treatments) and Therapeutic ultrasound (18 treatments) in Rhizarthrosis, sponsored by Waldfriede Hospital. Active, not recruiting at 1 site in Germany. Open to participants aged 40 Years to 90 Years. Per ClinicalTrials.gov, last updated 2023-05-12.
Sponsored by Waldfriede Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 131 studies in Osteoarthritis with a site in Germany — 12 open to participants now, 27 under way, 3 of them phase 3. Osteoarthritis · Germany.
Among the 131 studies in Osteoarthritis with a site in Germany, this one is the 37th largest by enrollment of the 98 interventional ones that give a count, is one of 2 that started in 2019, is one of 36 with no phase, reaches primary completion later than 0 of the 26 other live ones, and was the 109th registered.
2,974 studies on the registry are indexed under Osteoarthritis; 437 are open to participants now.
Browse Osteoarthritis studies →12 of the 131 studies in Osteoarthritis with a site in Germany are open now. Recruiting first, the newest first:
Eli Lilly and Company · Sites in Germany, United States, Argentina and 10 more countries
Ages 18+
University Hospital, Basel, Switzerland · Sites in Germany, Austria, Croatia and 5 more countries
Ages 18–70
Charite University, Berlin, Germany · Sites in Germany
Ages 18–50
University Hospital, Basel, Switzerland · Sites in Germany, Croatia, Switzerland
Ages 18–65
Charite University, Berlin, Germany · Sites in Germany
Ages 18–85
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 286 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 71 (25%) stop at 75 or younger; 22 take children under 18; 30 take healthy volunteers.
This study: 40 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
131 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 10 · Phase 2 24 · Phase 3 23 · Phase 4 12
First in 2000; this study’s year is marked. 2 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 200 is above the median of 80 across 2,240 interventional studies indexed under Osteoarthritis.
Median enrollment 139 across the 98 interventional studies, 100 across the 31 observational. Of the 96 that completed or were terminated, 28 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
94 of 131 have an industry lead sponsor. The 10 most frequent:
Waldfriede Hospital is the lead sponsor of 6 studies on the registry; 2 are open to participants now.
Waldfriede Hospital has 3 studies filed under Osteoarthritis — fewer than ten, so there is no comparison to draw.
7 of the studies in Osteoarthritis with a site in Germany that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07352540Phase 3University of Erlangen-Nürnberg Medical SchoolSingle vs Triple Hyaluronic Acid in Knee Osteoarthritis | 2026-12-15 |
| NCT02337244Zimmer, GmbHZimmer POLAR Persona - TKA (EMEA Study) | 2026-12 |
| NCT02351414MicroPort Orthopedics Inc.Post Market Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts | 2027-06 |
| NCT02823834MicroPort Orthopedics Inc.PMCF Study Protocol for PROFEMUR® Gladiator Plasma Femoral Stems and PROCOTYL® L Beaded Acetabular Components | 2027-06 |
| NCT02038140Zimmer BiometZimmer Trabecular Metal Total Ankle PMCF | 2027-09 |
Add all 7 to your calendar (.ics) → With an account.
Among the 131 studies in Osteoarthritis with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
It was never investigated which preservative non-invasive treatments are superior to treat rhizarthrosis. This randomized study compares the effect of 1. hand therapy vs. 2. therapeutic ultrasound vs. 3. hand therapy plus therapeutic ultrasound in the treatment of rhizarthrosis.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
9 weeks of standard hand therapy including two 20 min slots per week.
Procedure: Hand therapy (18 treatments)
9 weeks of standard ultra sound therapy including two 10 min slots per week.
Procedure: Therapeutic ultrasound (18 treatments)
9 weeks of standard hand therapy plus therapeutic ultrasound including two 30 min slots per week.
Procedure: Combined hand therapy and therapeutic ultrasound (18 treatments)
9 weeks of sham ultrasound therapy including two 10 min slots per week.
Procedure: Sham ultrasound group (18 treatments)
18 treatments (ea. 20 Min) within 9 weeks
18 treatments (ea. 10 Min) within 9 weeks
18 treatments (ea. 30 Min) within 9 weeks
Sham ultrasound group receive 18 treatments (ea. 10 Min) within 9 weeks
Disabilities of the Arm, Shoulder and Hand (DASH)
Disabilities as measured by the DASH scale; No Difficulty (1), Mild Difficulty (2), Moderate Difficulty (3), Severe Difficulty (4), Unable (5)
Time frame: Change after 9 weeks and 3, 4 and 8 months
Visual analogue scale (VAS) pain
From 0mm (no pain) to 100mm (maximum pain imaginable)
Time frame: Change after 9 weeks and 3, 4 and 8 months
Short Form 36 SF-36
Scored review of health questionnaire
Time frame: Change after 9 weeks and 3, 4 and 8 months
Functional assessment: Thumb force
Key pinch force measure of the thumb as measured in Kg.
Time frame: Change after 9 weeks and 3, 4 and 8 months
Functional assessment: Goniometry
Measurement of the angle between the dorsal axis of the thumb and the index finger with a goniometer.
Time frame: Change after 9 weeks and 3, 4 and 8 months
Plan to share: No
Started Oct 2019 (actual). Primary completion is estimated for Dec 2023, 50 months after the start.
Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 52. This study's planned 50 months is above that.
Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in May 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Waldfriede Hospital